台股 » 個股 » 台新藥 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

台新藥

(6838)
  • 股價
    34.75
  • 漲跌
    ▲0.70
  • 漲幅
    +2.06%
  • 成交量
    137
  • 產業
    上市 生技醫療類股
  • 20人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
台新藥 (6838)籌碼相關-元大-沙鹿 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-沙鹿 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/210.534.2000.0034.050.52790.16%
2025/01/20134.1000.0034.6012860.35%
2025/01/08535.1500.0035.0553161.58%
2025/01/07135.2000.0035.1013220.31%
2025/01/063.135.89136.2035.902.13240.64%
2025/01/02137.3500.0037.5013450.29%
2024/12/301.138.0000.0037.701.13800.28%
2024/12/2600.000.238.5538.60-0.2478-0.03%
2024/12/251.138.0000.0038.001.14820.23%
2024/12/230.238.000.138.8038.000.14920.02%
2024/12/200.137.8100.0037.650.15050.03%
2024/12/160.138.3000.0038.000.15600.01%
2024/12/130.139.3000.0039.000.15870.01%
2024/12/1100.000.139.7039.60-0.1643-0.01%
2024/12/1000.004.139.7039.80-4.1673-0.61%
2024/12/090.139.8000.0039.600.17300.01%
2024/12/06440.6500.0040.3047760.52%
2024/12/050.141.0000.0040.450.17830.01%
2024/12/045.141.5000.0041.605.17820.65%
2024/12/0300.00141.7541.75-1786-0.13%
2024/12/022.143.23243.8043.000.17820.01%
2024/11/2900.00342.5042.50-3767-0.39%
2024/11/28138.5000.0038.6517630.13%
2024/11/20139.5000.0039.2517900.13%
2024/11/180.140.8000.0039.900.18130.01%
2024/11/14142.00342.0041.25-2824-0.24%
2024/11/12242.8000.0042.7028760.23%
2024/11/0700.00344.2244.35-3977-0.31%
2024/11/06345.38444.6844.35-1980-0.10%
2024/11/05647.04147.0046.5559780.51%
2024/11/0400.00245.6045.80-2972-0.21%
2024/11/01544.3900.0045.3059660.52%
2024/10/284344.64344.9544.05409654.14%
2024/10/25345.3200.0045.1039750.31%
2024/10/2200.00143.8543.75-1981-0.10%
2024/10/21145.0500.0044.3019830.10%
2024/10/1700.00144.7044.50-1993-0.10%
2024/10/16144.7000.0044.5019970.10%
2024/10/1400.00544.7044.75-51,001-0.50%
2024/10/11145.405445.7145.75-53999-5.30%
2024/10/0900.00146.9046.00-1991-0.10%
2024/10/081146.36146.2046.35109851.01%
2024/10/07148.15348.3348.25-2970-0.21%
2024/10/04848.79848.0848.6509560.00%
2024/10/019.250.11350.7749.256.29350.66%
2024/09/30345.75148.2548.2528800.23%
2024/09/2500.00543.5543.15-5835-0.60%
2024/09/24543.9000.0043.5058410.59%
2024/09/231044.50744.6944.4538300.36%
2024/09/201345.13544.8244.6088220.97%
2024/09/191045.691245.3444.90-2817-0.24%
2024/09/18245.00344.3843.95-1802-0.12%
2024/09/161244.801245.1944.6507980.00%
2024/09/131045.39243.4346.0587781.03%
2024/09/12242.60142.5041.9017360.14%
2024/09/113.143.28343.6542.500.17230.02%
2024/09/1028.145.44247.3045.5026.16943.76%
2024/09/091.143.7500.0043.751.16350.17%
2024/09/060.239.3900.0039.800.25900.03%
2024/09/02339.5000.0038.9035740.52%
2024/08/27138.7000.0038.6515580.18%
2024/08/230.139.0500.0039.000.15470.01%
2024/08/202.138.9500.0039.202.15290.39%
2024/08/1600.00139.7039.65-1498-0.20%
2024/08/150.140.00340.0739.90-2.9489-0.60%
2024/08/141.141.12239.5039.55-0.9477-0.19%
2024/08/1311.139.74139.3041.9510.14382.31%
〈焦點股〉台新藥眼科新藥出貨至美國展望正向 觸及漲停Anue鉅亨-2024/09/13
〈焦點股〉台新藥眼科新藥9月正式外銷至美國 漲逾半根停板Anue鉅亨-2024/09/06
台新藥 相關文章
台新藥 相關影音